Skip to content
🧪 Theranos

Theranos investigation — Journal, CMS, SEC, and DOJ

What reporters, laboratory regulators, the SEC, and federal prosecutors did after 2015 to test Theranos’s claims — an after-the-fact record, not a product manual.

The Theranos investigation in public view begins with journalism, then laboratory regulation, then securities and criminal process.

This page records those steps. It does not explain how to falsify a validation study or how to present a device that is not ready.

Agencies

What followed

  1. Source interviews

    Journal reporters interviewed former scientists and lab staff and compared their accounts with the public testing menu.

  2. Publication

    The 15 October 2015 article forced Theranos into public rebuttal and drew CMS and state attention to the Newark lab.

  3. CLIA inspection

    Surveyors reviewed quality-control records and proficiency testing; findings led to sanctions and voided results.

  4. Civil securities case

    The SEC charged fraud in 2018; Holmes settled those civil claims without admitting or denying the complaint’s allegations, on terms in the decree.

  5. Indictment and discovery

    Prosecutors obtained emails, texts, and investor materials and split the two defendants for trial.

  6. Two jury trials

    Holmes’s case ended 3 January 2022; Balwani’s ended in July 2022. Sentencing hearings closed the trial court year.

Turning points

After-the-fact investigators tested claims against laboratory records and investor decks. The science story ended when those records could not support the pitch.

Public-record encyclopedia. Not legal advice. Not a how-to. Graphic detail is withheld. Wars belong in a separate atlas.

Related cases